The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2023 | Improving patient knowledge of medicine relating to CLL
In this interview, Lorna Warwick, BA, Lymphoma Coalition, Ontario, Canada, acknowledges the increase in treatment options for chronic lymphocytic leukemia (CLL) which has occurred in recent years and which has led to a vast influx of information for clinicians to understand and explain to patients. As contact between clinicians and patients is often limited, patients should be directed to reputable sources which will aid them in understanding key terms related to their disease. This interview was recorded at the biennial International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2023 meeting, held in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
